Conference
Cardiomedex to present NASH hamster model at the AHA 2023
Join us at the American Heart Association meeting taking place from 10th to 13th November 2023 in Philadelphia, PA, USA. Cardiomedex is very excited to be sharing the latest results confirming the clinical relevance of the diet-Induced Obese NASH Hamsterfor evaluating...
Cardiomedex to present a HFpEF hamster model at the 37thAnnual Meeting of the International Society of Heart Research (ISHR)July 10th-13th in Porto,Portugal
Cardiomedex will be presenting a new HFpEF hamster model at the 37th Annual Meeting of the ISHR in Porto, Portugal from 10th to 13th of July2023. This unique preclinical model will be presented during the July 10thposter session (poster #PO55) from 16:30-18:00 by...
Physiogenex and Cardiomedex to present the SDT fatty rat model at ISN-World Congress of Nephrology in Bangkok, Thailand, March 30-April 2, 2023
Physiogenex, its subsidiary company Cardiomedex, and its partner CLEA Japan Inc., will be presenting their collaborative work at the ISN-World Congress of Nephrology, to be held March 30-April 2 in Bangkok, Thailand. Dr. François Briand, Director of Research and...
Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference on type 2 Diabetes therapeutics, May 1-4 in Palm Springs, CA, USA
Physiogenex and its subsidiary company Cardiomedex will be presenting a new diabetic NASH HFpEF hamster model at the Keystone Symposia on type 2 diabetes therapeutics in Palm Springs, CA, USA May 1-4, 2023. This unique preclinical model will be presented during the...